Conflicting evidence exists on the relationship between diabetes mellitus (DM) and
Alzheimer's disease (AD) biomarkers. Therefore, we conducted a random-effects meta …

For their stability and detectability faecal microRNAs represent promising molecules with
potential clinical interest as non-invasive diagnostic and prognostic biomarkers. However …

Background: Obesity is related to quantitative neuroimaging abnormalities including
reduced gray matter volumes and impaired white matter microstructural integrity, although …

In the present study, we tested the hypothesis that higher amyloid-beta (Aβ) burden at
baseline is associated with greater longitudinal decline in body mass index (BMI) in …

Background While obesity in midlife is a risk factor for dementia, several studies suggested
that obesity also protected against dementia, hence so-called obesity paradox. The current …

Introduction: Cognitive deficits in people with schizophrenia (PWS) are a major predictor of
disability and functioning, yet the underlying pathophysiology remains unclear. A possible …

Background Developing a screening method for identifying individuals at higher risk of
elevated brain amyloid burden is important to reduce costs and burden to patients in clinical …

Propose This study aims to explore the use of the Centiloid (CL) method in amyloid-β PET
quantification to evaluate distinct cognitive aging stages, investigating subjects' mismatch …

Objectives The relationship of body mass index (BMI) changes and variability with amyloid-β
(Aβ) deposition remained unclear, although there were growing evidence that BMI is …

Dietary pattern (DP) results in nutrition adequacy and may influence cognitive decline and
cortical atrophy in Alzheimer's disease (AD). The study explored DP in 248 patients with AD …